blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1117688

EP1117688 - D-1 LIKE DOPAMINE RECEPTOR ACTIVITY MODIFYING PROTEIN [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  03.03.2006
Database last updated on 03.06.2024
Most recent event   Tooltip21.11.2008Change - lapse in a contracting state
Updated state(s): FR
published on 24.12.2008  [2008/52]
Applicant(s)For all designated states
Medical College Of Georgia Research Institute, Inc.
1120 15th Street
Augusta, GA 30912-4810 / US
[N/P]
Former [2001/30]For all designated states
Medical College Of Georgia Research Institute, Inc.
1120 15th Street
Augusta, GA 30912-4810 / US
Inventor(s)01 / BERGSON, Clare
3633 Highlands Circle
Martinez, GA 30907 / US
 [2001/30]
Representative(s)Boff, James Charles, et al
Phillips & Leigh
5 Pemberton Row
London EC4A 3BA / GB
[N/P]
Former [2005/10]Boff, James Charles, et al
Phillips & Leigh, 5 Pemberton Row
London EC4A 3BA / GB
Former [2001/30]Farwell, William Robert, et al
PHILLIPS & LEIGH 5 Pemberton Row
London EC4A 3BA / GB
Application number, filing date99951895.408.10.1999
[2001/30]
WO1999US23565
Priority number, dateUS19980103786P09.10.1998         Original published format: US 103786 P
US19990130609P22.04.1999         Original published format: US 130609 P
[2001/30]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0021997
Date:20.04.2000
Language:EN
[2000/16]
Type: A1 Application with search report 
No.:EP1117688
Date:25.07.2001
Language:EN
The application published by WIPO in one of the EPO official languages on 20.04.2000 takes the place of the publication of the European patent application.
[2001/30]
Type: B1 Patent specification 
No.:EP1117688
Date:27.04.2005
Language:EN
[2005/17]
Search report(s)International search report - published on:EP20.04.2000
ClassificationIPC:C07K14/47, C12N15/12, G01N33/68
[2001/30]
CPC:
C07K14/4702 (EP,US); G01N33/9413 (EP,US); G01N2500/00 (EP,US)
Designated contracting statesCH,   DE,   FR,   GB,   IT,   LI [2004/21]
Former [2001/30]AT,  BE,  CH,  CY,  DE,  DK,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE 
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:PROTEIN, WELCHES DIE AKTIVITÄT VON D1-ÄHNLICHEN DOPAMIN REZEPTOREN MODIFIZIERT[2001/30]
English:D-1 LIKE DOPAMINE RECEPTOR ACTIVITY MODIFYING PROTEIN[2001/30]
French:PROTEINE MODIFIANT L'ACTIVITE DU RECEPTEUR DE DOPAMINE DE TYPE D1[2001/30]
Entry into regional phase04.05.2001National basic fee paid 
04.05.2001Designation fee(s) paid 
04.05.2001Examination fee paid 
Examination procedure03.05.2000Request for preliminary examination filed
International Preliminary Examining Authority: EP
04.05.2001Examination requested  [2001/30]
02.10.2003Despatch of a communication from the examining division (Time limit: M04)
11.02.2004Reply to a communication from the examining division
11.03.2004Despatch of a communication from the examining division (Time limit: M04)
16.07.2004Reply to a communication from the examining division
11.10.2004Communication of intention to grant the patent
10.02.2005Fee for grant paid
10.02.2005Fee for publishing/printing paid
Opposition(s)30.01.2006No opposition filed within time limit [2006/16]
Fees paidRenewal fee
11.10.2001Renewal fee patent year 03
15.10.2002Renewal fee patent year 04
14.10.2003Renewal fee patent year 05
14.10.2004Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCH27.04.2005
FR27.04.2005
IT27.04.2005
LI27.04.2005
DE28.07.2005
[2008/52]
Former [2008/45]CH27.04.2005
IT27.04.2005
LI27.04.2005
DE28.07.2005
FR31.10.2005
Former [2008/18]CH27.04.2005
IT27.04.2005
LI27.04.2005
DE28.07.2005
Former [2006/35]CH27.04.2005
LI27.04.2005
DE28.07.2005
Former [2006/14]CH27.04.2005
LI27.04.2005
Cited inInternational search[E]WO9958642  (GENETICS INST [US]) [E] 5-9 * SEQ ID NO:119 and 120; page 187, line 3 - page 190, line 2 *;
 [A]  - JARVIE K R ET AL, "DOPAMINE-D1A AND D1B RECEPTORS. DOPAMINE RECEPTOR HETEROGENEITY", DOPAMINE RECEPTORS AND TRANSPORTERS: PHARMACOLOGY, STRUCTURE AND FUNCTION, page 133-150, XP000652346 [A] * the whole document *
 [A]  - LIN CW, ET AL., "Characterization of Cloned Human Dopamine D1 Receptor-Mediated Calcium Release in 293 Cells", MOLECULAR PHARMACOLOGY, (199501), vol. 47, no. 1, pages 131 - 139, XP000872342 [A] * the whole document *
 [PX]  - EUBANKS, S. (1) ET AL, "Cloning of a novel neuronal dendritic protein that interacts with D1 dopamine receptors.", SOCIETY FOR NEUROSCIENCE ABSTRACTS, (1998) VOL. 24, NO. 1-2, PP. 1359. MEETING INFO.: 28TH ANNUAL MEETING OF THE SOCIETY FOR NEUROSCIENCE, PART 2 LOS ANGELES, CALIFORNIA, USA NOVEMBER 7-12, 1998, XP000872352 [PX] 1-15 * abstract *
 [T]  - STRAUSENBERG R, "tm71b06.x1 Homo sapiens cDNA clone (EST)", EMBL, (19990317), XP002129847 [T] * abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.